- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06745570
Improving Sleep, Decision-Making, and Eating in Adolescents with Obesity (STAR)
December 17, 2024 updated by: Stephanie Manasse, Drexel University
Improving Sleep As a Method for Enhancing Decision-Making and Reducing Problematic Eating Behaviors in Adolescents with Obesity
This study is being performed to understand the effects of a lifestyle modification and sleep intervention on weight loss outcomes in adolescence. The main question the study aims to answer is:
- What are the initial effects of a lifestyle modification and sleep intervention, including effects on weight, eating behaviors and dietary intake, and sleep?
Participants will:
- Participate in remote, group-based, weekly weight loss and sleep coaching for 16 weeks.
- Complete study assessments at baseline (pre-intervention), mid-intervention, and post-intervention.
- Complete daily sleep diaries for three 7-day periods at each assessment point.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
In this study, the investigators will develop, refine, and test a 16-session group-based lifestyle modification intervention for adolescents with overweight and obesity augmented with a sleep intervention.
The investigators will develop the manual and pilot the intervention in an initial set of adolescents (n=10).
The investigators will collect feedback from adolescents, parents, and clinicians, which will inform manual refinements.
The investigators will complete an open trial (n=40) of the refined manual.
For both phases, the investigators will recruit adolescents (ages 14-18) with overweight or obesity who endorse at least 1 type of sleep disturbance (i.e., too little, poor quality, poorly timed, or inconsistent sleep).
Assessments of sleep, decision-making, problematic eating behaviors, energy intake, and weight will occur at baseline (week 0), mid-intervention (week 8) and post-intervention (week 16).
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Drexel University WELL Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ages 14-18
- Fluent in English
- BMI percentile ≥ 85th percentile for sex-and-age
- Has a parent or guardian who is willing and able to participate
- Has at least one sleep disturbance. Eligible sleep disturbances are: a. Advanced sleep timing (sleep onset 11:00pm or later for 14-16 year-olds or 11:20pm or later for 17-18 year-olds at least 3 times per week), b. Difficulty falling asleep (taking ≥ 30 mins to get to sleep 3 or more nights per week), c. Short sleep (obtaining < 7.5 hours of sleep per night 3 or more nights per week), and d. Sleep irregularity (having more than 2 hours of variability in sleep-wake schedule across one week
Exclusion Criteria:
- Experience of weight loss of ≥ 5% of body weight in the past 6 months
- Current use of insomnia medication
- Having recently begun or changed the dosage of any medication known to affect appetite or body composition within the last 3 months
- Currently taking weight loss medications
- Currently taking insulin
- Diagnosed diabetes (type 1)
- Any condition prohibiting physical activity
- Diagnosis of an eating disorder
- Diagnosis of obstructive sleep apnea
- Recent or ongoing problem with drug abuse, alcohol abuse, or addiction
- Currently pregnant or less than 3 months postpartum
- Anticipation of a possible pregnancy in the next year
- Unwillingness to report possible or confirmed pregnancies promptly during the course of the trial
- Currently participating in treatment for eating or weight concerns
- Does not have regular access to Wi-Fi connection to participate in study interventions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group Intervention
All participants will receive group-based lifestyle modification and sleep treatment (16, 90-minute sessions over 16 weeks).
All sessions will be delivered on Zoom (remotely) to small groups (n=5-10 each) of participants.
The intervention involves lifestyle modification content (e.g., nutritional education, physical activity education, stimulus control, goal setting) and sleep content (e.g., psychoeducation regarding sleep and eating behavior, sleep tracking, establishing regular sleep-wake times).
|
This study is being performed to develop, refine, and test the effects of a group lifestyle modification intervention augmented with a sleep intervention on weight loss, eating behaviors, and sleep outcomes.
Results from this study will inform future studies to test the efficacy of this intervention.
This intervention is being offered as part of a research study within Drexel University's WELL Center.
Participants will receive remote, group-based, weekly weight loss and sleep coaching (90 minutes per coaching session) for 16 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of 95th percentile BMI
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Height and weight will be measured at each assessment and used to calculate percent of 95th percentile BMI.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Tri-ponderal mass index
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
The investigators will also calculate tri-ponderal mass index (TMI; i.e., mass divided by height cubed) from measurements of height and weight.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Body fat percentage
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Body fat percentage will also be derived from the Aria Air scale.
|
From enrollment to the end of the study (approximately 4 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary intake
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Adolescent dietary intake will be assessed via 30-day dietary recalls using the VioScreen at the baseline and post-treatment assessments.
This freely available and validated web-based tool enables automated, self-administered, 30-day recalls.
The VioScreen provides item-level nutritional information as well as monthly totals of key nutrient variables.
Mean intake of the following food/macronutrient groups will be calculated: fruits and vegetables, fat, saturated fat, protein, cholesterol, added sugars, and dietary fiber.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Eating Disorder Examination
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
The investigators will also assess adolescent eating behaviors using the Binge Module and the Compensatory Behaviors Module portions of the Eating Disorder Examination at each assessment point.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Eating Disorder Examination Questionnaire
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
The investigators will have adolescents and their parents complete the Eating Disorder Examination Questionnaire, a self-report measure of eating behaviors, and baseline and post-treatment.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Average total sleep time
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention.
Average total sleep time will be calculated.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Average bed time
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention.
Average bed time will be calculated.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Average sleep latency
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention.
Average sleep latency will be calculated.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Average weekday-weekend bed time shift
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Adolescent sleep diaries will be collected for a 1-week period prior to the initiation of the intervention, 1 week at mid-intervention and 1 week following the intervention.
Average weekday-weekend bed time shift will be calculated.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Pittsburgh Sleep Quality Index
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Adolescents and their parents will complete the Pittsburgh Sleep Quality Index, a well-validated overall measure of sleep quality, at each assessment point.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Morningness Eveningness Questionnaire
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
The investigators will use the Morningness Eveningness Questionnaire at each assessment point to assess differences in the degree to which adolescents are active and alert at certain times of the day.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Insomnia Severity Index
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
The investigators will have participants complete the Insomnia Severity Index to assess insomnia.
|
From enrollment to the end of the study (approximately 4 months)
|
|
Sleep - Fitbit data
Time Frame: From enrollment to the end of the study (approximately 4 months)
|
Participants will wear a FitBit during the assessment weeks, which will gather accelerometry data on sleep.
|
From enrollment to the end of the study (approximately 4 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephanie Manasse, Ph.D., Drexel University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 18, 2024
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
January 31, 2027
Study Registration Dates
First Submitted
December 9, 2024
First Submitted That Met QC Criteria
December 17, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 17, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2310010117
- R03DK138216 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
Clinical Trials on Lifestyle Modification and Sleep Intervention
-
Taipei Medical UniversityMinistry of Health and Welfare, TaiwanUnknown
-
University of OuluOulu University Hospital; Oulu Deaconess Institute Foundation srCompletedObesity | Physical Activity | Weight Loss | Healthy Obesity, MetabolicallyFinland
-
Chang Gung University of Science and TechnologyCompletedObstructive Sleep ApneaTaiwan
-
Chinese University of Hong KongCompletedObstructive Sleep ApneaChina
-
Maastricht University Medical CenterMaastricht UniversityCompletedChildhood Obesity | Underweight | Overweight (BMI > 25)India
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Aga Khan UniversityCompleted
-
The University of Hong KongSuspendedInsomnia | PreDiabetes | Sleep DeprivationHong Kong
-
University of PennsylvaniaSt. Luke's-Roosevelt Hospital CenterCompletedObesity | OverweightUnited States
-
University Hospital, GrenobleRecruitingLifestyle Risk Reduction | Inactivity, PhysicalFrance